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ABSTRACT
No mechanistic link has tied inflammation to suppression of feed intake. In
rodents, an acute phase protein, α-1-acid glycoprotein (AGP), could provide this link by
acting as a leptin receptor agonist. The objective of these studies was to determine the
effects of AGP on food intake and rectal temperature in sheep. In the first experiment
ewes (n=4) received 1 of 4 treatments [0 (control), 0.012 (low), 0.06 (medium), or 0.30
(high) mg / kg BW AGP] into the lateral ventricle. The study was repeated until all sheep
received all treatments. In the second experiment ewes (n=10) received one of two
treatments (0 and 3 mg / kg BW of AGP) intravenously. In the third experiment ewes (n
= 19) received peripheral treatments (IV) of an antipyretic [0 (control) or 2.2 mg / kg BW
flunixin meglumine] 30 minutes prior to receiving central treatments (ICV) [0 (control)
or 0.3 mg / kg BW AGP]. In the first experiment there was no effect of treatment on feed
intake rate (P = 0.37) or cumulative feed intake (P = 0.31). There was an effect of
treatment on rectal temperature (P = 0.002) such that rectal temperatures were greater (P
< 0.05) following the high dose of AGP. In the second experiment there was no effect of
treatment on feed intake rate (P = 0.98), on cumulative feed intake (P = 0.41) or on rectal
temperature (P = 0.71). In the third experiment there was an effect of central treatment (P
< 0.0001) and an interaction of central treatment and time (P < 0.0001). There was no
effect of peripheral treatments (P = 0.93) on rectal temperature, indicating that central
AGP may increase rectal temperature in sheep by pathways that do not involve
prostaglandins. Further research is needed to determine if AGP may be an important
integrator of energy balance and inflammation.
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CHAPTER I
LITERATURE REVIEW
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POSTPARTUM INFLAMMATION
Systemic inflammation is common in the first week of lactation. Inflammation is
the host protective response to pathogenic (e.g., infection or non-pathogenic (e.g., stress))
damaging stimuli. Recently, Bradford and others (2015) highlighted the major differences
between acute and sub-acute/metabolic inflammation in dairy cows. Briefly,
inflammatory molecules promote increased blood flow to the infected tissue, immune cell
infiltration and activation, and systemic responses, including increased body temperature,
increased heart rate, and decreased feed intake. In contrast, “metabolic inflammation” is
characterized by its sub-acute, chronic nature and subtle shifts in both immune cell and
metabolic function. The presence of an inflammatory state in the postpartum period has
been documented in a number of species, including cattle (Humblet et al., 2006, Mullins
et al., 2012), mice (Gregor et al., 2013), pigs (Rosenbaum et al., 2012a, b), and humans
(Disilvestro, 1986). Unlike inflammation associated with a local infection, the postpartum
inflammatory state has no clear focal organ and does not necessarily induce the
traditional signs of inflammation (fever, swelling, pain). Rather, inflammation during this
period is systemic and sub-acute, consistent with the concept of metabolic inflammation.
Although data are limited, mammary (Clarkson et al., 2004), liver (Loor et al., 2005), and
adipose (Sadri et al., 2010, Gregor et al., 2013) tissue all show increased inflammatory
signals in early lactation, and other metabolic organs are also likely affected.
One effect of cytokines is to activate production of acute phase proteins. Primarily
produced by the liver, this class of proteins includes haptoglobin, serum amyloid A, C-
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reactive protein, and alpha-1-acid glycoprotein (AGP). Proteins that participate in the
acute phase response to infection are generally found in very low abundance in the
bloodstream, but are greatly elevated during periods of systemic inflammation. The
presence of an acute phase response in postpartum dairy cows is well established.
Numerous studies in the past decade have demonstrated that inflammatory and acute
phase mediators are elevated in the days after parturition, even in cows that are
apparently healthy (Humblet et al., 2006, Bionaz et al., 2007, Huzzey et al., 2009,
Graugnard et al., 2012, Mullins et al., 2012, Qu et al., 2014). This growing body of
evidence suggests that either the processes of parturition and galactopoiesis induce
inflammation directly or that infections or endotoxin affect far more postpartum cows
than is currently recognized. Whatever the explanation, the prevalence of postpartum
inflammation raises important questions about the implications of this inflammation on
central regulation of feed intake.
Greater degrees of inflammation are associated with poor performance. Although
most transition dairy cows apparently go through a period of inflammation, the
magnitude of this inflammatory condition varies greatly between cows. Bertoni et al.
(2008) assessed the importance of this variation by measuring a panel of inflammatory
markers and separating transition cows into quartiles for degree of inflammation. Cows in
the highest quartile had significantly lower milk yields, greater proportions of cows with
health problems, and lower conception rates. One metric that has been used in this respect
is paraoxanase, a plasma biomarker that is potently suppressed by a variety of
inflammatory stimuli. Transition cows with high paraoxanase concentrations, in addition
3

to having lower concentrations of acute phase proteins and reactive oxygen metabolites,
produced more milk, and had lower proportion of cows reporting at least one health
problem (Bionaz et al., 2007). Because haptoglobin is the acute phase protein reaching
the highest concentration in response to inflammation in ruminants, it has been widely
used as an inflammatory marker. Recently, a greater magnitude of inflammatory
response, measured in terms of circulating haptoglobin, during the transition period was
associated with an impaired performance (Huzzey et al., 2015). Increments of 1 g/L of
haptoglobin at -2, -1 and +1 weeks relative to parturition reduced whole-lactation milk
yield by ~ 500 kg. Furthermore, increase of postpartum haptoglobin was negatively
associated with hazard of conception (0.70 – 0.97, 95% coefficient interval). More
recently (McCarthy et al., 2016), cows were categorized in 4 quartiles of inflammation
based on plasma haptoglobin concentration during the first week postpartum.
Interestingly, cows in Q2 and Q3 (moderate inflammation) had lower dry matter intake
and BW postpartum, coupled with tendency for lower fat- and energy-corrected milk.
These longitudinal studies strengthen the established links between postpartum
inflammation and negative health and production outcomes. Additionally, incidence of
diseases such as metritis, mastitis, and others have been evaluated using, the acute phase
protein, AGP as a potential marker for disease incidence (Tamura et al., 1989, Eckersall
et al., 2001, Sheldon et al., 2001, Cairoli et al., 2006), albeit using a more limited number
of cows (n = 10 to 90) as compared with studies with haptoglobin cited above (n = 67 to
412). The limitation of associative data is that its interpretation is difficult because it does
not demonstrate causation. While it is possible that these studies identified cows with
4

primary inflammatory conditions that impaired feed intake and overall performance, it is
also possible that impaired intake exacerbates inflammation, impairing health and
productivity. To carefully determine whether inflammation or intake is the primary cause
of peripartum disorders, more controlled studies are required.
Feed Intake
In spite of the great body of research in dairy cattle and many other species to
identify the role of inflammatory and acute phase mediators on metabolic function, little
research has focused on studying their role in feed intake regulation. Feed intake
regulation is a complex phenomenon integrating peripheral and central signals in the
hypothalamus. Regulation of feed intake has been a focus of research for many years. In
ruminants, attempts to develop models for intake prediction are mostly focused on
physical and chemical factors (Ingvartsen and Andersen, 2000). Forbes extensively
studied physical regulation of intake and attempted to study its interaction with metabolic
regulators and neuronal signaling (Forbes, 1980, 1996). Studies across many decades
have identified numerous metabolic compounds and hormones that influence
hypothalamic signals of satiety or hunger (Ingvartsen and Andersen, 2000, Allen and
Piantoni, 2013). The physiological mediators of metabolite responses are complex and
diverse; among several proposed mechanisms of peripheral regulation of intake, the
hepatic oxidation theory appears to be the best suited for ruminants accounting for
differences in fuels absorbed and sites of absorption (Allen et al., 2009, Allen and
Bradford, 2012).
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Marked depression in feed intake is common during the peripartum period. After
17 years and despite of the great body of research we still are unable to answer a key
question formulated by Drackley (1999): “what controls dry matter intake during the
transition period?” Variability in feed intake during the first week postpartum is 30 to
40%, whereas DMI variation after peak lactation is only 6 to 10% (Drackley, 1999).
Dairy cows at parturition face a drastic increase in nutrient requirements (2 to 4x for
many nutrients) driven by the increased demands for milk production, which are
compensated by increases in hepatic gluconeogenesis and mobilization of body stores of
fat, protein, and calcium (Roche et al., 2013). Dry matter intake during the first week of
lactation only increases by 30 to 50%, and if this increase is delayed, it forces the cow to
mobilize excessive amount of body reserves, exacerbating the risk of metabolic disorders
and disease development (Ingvartsen et al., 2003). Inflammation during the first week of
lactation is associated with depressed feed intake in dairy cows (Bertoni et al., 2008,
McCarthy et al., 2016).
Although no associations of intake and AGP have been reported for ruminants, a
study involving dairy cows, Jafari et al. (2006), evaluated the infusion of three levels of
glutamine on dry matter intake and plasma concentrations of AGP in transition cows.
Using data from that study, a negative association was found between dry matter intake
adaptation to lactation and the rise in plasma AGP after parturition. Using mean values
for dry matter intake and AGP for days 7 to 21 (n = 9), it was found that AGP was
negatively associated with dry matter intake (r = 0.90; P = 0.001).
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Rectal Temperature
Fever, known by an elevated body temperature, is well known in response to
inflammation or infections. Many exogenous pyrogens (ex: lipopolysaccharide; LPS) can
cause a fever. The presence of these substances induce the production of proteins called
cytokines. Cytokines such as, tumor necrosis factor alpha (TNF-α) and other interleukins,
have been found in circulation (Kluger, 1991, Jansky et al., 1995), however changes in
interleukin-6 concentrations in the rat best match the change in temperature produced by
administration of LPS (Lemay et al., 1990). Cytokines have various routes to access the
brain. Described in a review by Blomqvist and Engblom (2018) are four routes used to
bypass the blood-brain-barrier and get the signals to the brain. Thermosensitive neurons
in the hypothalamus are exposed to cytokines at the onset of a temperature. Researchers
found that administering endogenous pyrogens released fever inducing prostaglandins
(Feldberg and Saxena, 1971). Soon thereafter, Vane (1971) administered the antipyretic
drug, aspirin, for prostaglandin inhibition and decreased the induced fever.
LEPTIN
Introduction
One of the most important endocrine factors is leptin, a cytokine-like hormone
produced by adipose tissue. Leptin, known for its homeostatic regulation of adiposity, is
one of the main contributors in energy homeostasis, proving that obesity can be a sign of
resistance to its role (Ahima and Flier, 2000, Munzberg and Myers, 2005). Leptin exerts
its suppression effects in intake regulation principally through its long-form receptor
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(LepRb) in the hypothalamus. There are six isoforms of the leptin receptor, among those,
LepRb is the only isoform with capacity to transmit leptin signaling and initiate the
signaling response (Kwon et al., 2016). Neurons located in the hypothalamus monitor
energy status by sensing concentrations of hormones (e.g., leptin; (Ingvartsen and
Boisclair, 2001)) and nutrients (e.g., free fatty acids; (Obici et al., 2002)).
Leptin Background
The concept began with the discovery of two recessive mutations in mice, obese
(ob) and diabetes (db), with the effects of hyperphagia, decreased energy expenditure,
and early onset obesity (Ingalls et al., 1950). The joining of two mice, known as
parabiosis, showed that when a normal wild-type mouse was joined with an ob/ob mouse,
the obese model mouse began to lose weight (Hausberger, 1958). However, parabiosis of
the db/db model found the wild-type mouse suffering from hypophagia (Coleman and
Hummel, 1969, Coleman, 1973). This information led to the discovery of their role: the
ob gene product was named leptin (from the Greek root, leptos, which translates meaning
thin) because of its effects on leptin-deficient and normal mice (Halaas et al., 1995). The
db locus is needed for response to the satiety factor.
Leptin Pathway in the Brain
For leptin, several signaling pathways can mediate the hypothalamic actions, with
most effects thought to be via the JAK/STAT signaling pathway. After leptin binds to
LepRb, downstream signaling through the sequential phosphorylation of the tyrosine
kinase janus kinase (JAK) and the transcription factor signal transducer and activators of
8

transcription (STAT) is initiated. Phosphorylated STAT3 is translocated to the nucleus
where it modulates the transcription of genes involved in feed intake, resulting in altered
neuropeptide production and release (Vaisse et al., 1996). Leptin increases the
transcription of proopiomelanocortin (POMC) which in turn stimulates the synthesis of αmelanocyte stimulating hormone (α-MSH), which exerts its anorexigenic (intake
inhibition) effect by binding to the melanocortin-4 receptor (MC4R) in the hypothalamus
(Ellacott and Cone, 2004). Additionally, leptin inhibits the neuronal activity of agoutirelated protein (AgRP) and reduces the expression of neuropeptide Y (NPY) and AgRP,
both orexigenic (intake-promoting) neuropeptides. The net effect of leptin signaling is
therefore a decrease in feed intake (Myers et al., 2008).
Leptin in Rodents
With the center of leptin research established in the rodent model, the
mechanisms and purpose of this hormone are fairly clear. However, further research
continuously discovers more about it. There are both central and peripheral mechanisms
that control leptin’s effect on food intake and energy expenditure. Leptin receptors are
expressed in most tissues of the rodent. In rodent models, mutations in the leptin and
leptin receptor genes can result in morbid obesity, infertility, and insulin resistance (Chua
et al., 1996, White et al., 1997, Farooqi, 2002, Perry et al., 2014). It has been determined
that administration of central leptin in rats increases body temperature (Luheshi et al.,
1999, Turek et al., 2004, Skibicka and Grill, 2009). As with inflammatory studies in the
past, Luheshi et al. (1999) administered a cyclo-oxygenase inhibitor, flurbiprofen, and
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was able to block the leptin-induced temperature via the prostaglandin pathway. More
recently, researchers are using leptin, in a diabetic model, to find a mechanism that will
help diminish type I diabetes (Kadota et al., 2018).
Leptin in Ruminants
Leptin properties in the ruminant model has shown similar results as human and
rodent research (Chilliard et al., 2001). For example, ovine leptin given centrally to goats
and sheep was found to reduce food intake (Clarke et al., 2001). Plasma leptin is higher
in sheep and cows with higher body fatness (Blache et al., 2000, Delavaud et al., 2000).
These few examples in ruminant species are parallel with those in mice and humans.
However, the factor that sets them apart is the discovery of leptin levels, unlike in nonruminant studies, does not increase in response to inflammatory indicators. Rodent
studies have shown that administration of LPS peripherally causes an increase of plasma
leptin levels, suggesting a role of leptin in anorexia induced by endotoxin (Francis et al.,
2000). In sheep, however, peripheral administration of LPS had no effect on plasma
leptin concentrations but sheep still showed signs of anorexia and fever (Soliman et al.,
2001)). Soliman and others (2002) then continued by replicating this experiment in cattle.
The plasma leptin concentrations from these cows were not changed for 8 hours, showing
almost the same concentration as those in saline-injected controls. These discoveries
suggest that leptin may not be involved in anorexia and fever in ruminants with
inflammatory status.
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ALPHA-1-ACID-GLYCOPROTEIN
Introduction
Alpha-1-acid-glycoprotein, (AGP) also known as orosomucoid, is a versatile
acute phase protein with diverse roles. From rodent studies, it is now known that AGP
exerts some anti-inflammatory and immunomodulatory properties (Hochepied et al.,
2003). More recently, AGP has been identified as a protein capable of integrating
inflammatory and metabolic signals to modulate immune responses, protecting adipose
tissue from excessive inflammation by improving glucose and insulin tolerance in mice
(Lee et al., 2010). It has also been reported that AGP was consistently found in high
concentrations around parturition, and has been associated with greater incidence of
several diseases in cattle (Tamura et al., 1989, Eckersall et al., 2001, Sheldon et al., 2001,
Cairoli et al., 2006). In the early 1990’s a new role for AGP was discovered by
serendipity when Bellinger et al. (1990) were investigating the purity of extracted
satietin, a putative hypophagic endocrine factor in plasma. Bellinger and coworkers
found that the extracted satietin was contaminated with other plasma proteins (e.g.,
albumin and AGP). After further purification and isolation, they determined that centrally
administered purified AGP was also able to induce hypophagia in rodents.
Alpha-1-acid-glycoprotein in the Leptin Pathway
Since the early 1990’s, the putative role of AGP was not evaluated further until a
recently published paper in Diabetes (Sun et al., 2016) thoroughly documented the role of
AGP as a hypophagic compound, signaling via the long form leptin receptor to reduce
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feed intake. Sun and Coworkers (2016) fed C57BL/6 or db/db mice with a normal diet.
Feed intake was reduced in C57BL/6 mice but not in db/db in response to intraperitoneal
infusions of AGP for four consecutive days. The lack of hypophagic effect of AGP in
db/db mice led authors to hypothesize that AGP signals via LepR. Subsequently, they
silenced LepR in the hypothalamus of C57BL/6 mice and demonstrated that the
hypophagic effects of AGP were blocked.
This discovery immediately found ruminant researchers discussing the possibility
of AGP playing a role in hypophagia of cattle under inflammatory conditions. The
Bradford group has been investigating the systemic effects of inflammation during the
immediate postpartum period in cattle (Bradford et al., 2015). To mimic systemic
inflammation, the Bradford group subcutaneously administered recombinant TNFα to 33
transition cows assigned to control (carrier), low dose (1.5 μg/kg BW), or high dose (3.0
μg/kg) daily from day 1 to 7 of lactation (Yuan et al., 2013). This treatment protocol
performed did not induce pyrexia or other acute responses because the subcutaneous
route of administration slowed the appearance of the protein in circulation. The mild
elevation in plasma TNFα nevertheless induced an increase in plasma haptoglobin and
had a dramatic impact on dry matter intake and milk production by significantly
decreasing dry matter intake and milk yield throughout the first week of lactation.
Bradford et al. (2015) results were inconsistent with the hypothesis that inflammation in
early lactation primarily influenced liver function; rather, inflammation during this period
altered mammary and/or neurological function greatly.
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CONCLUSIONS
In summary, if AGP acts as a LepRb agonist in ruminants, as reported in mice
(Sun et al., 2016), it’s increase during peripartum inflammation may be the link between
inflammation and hypophagia that is a common precursor to common metabolic and
infectious disorders in early lactation dairy cows. Research regarding the possibilities of
alpha-1-acid-glycoprotein in inflammatory models is ongoing. This should give a greater
insight to the many diverse roles that leptin and its receptor play in the ruminant model,
just as recently discovered by serendipity in the rodent model.
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CHAPTER II
EFFECTS OF CENTRAL AND PERIPHERAL ADMINISTRATION
OF AN ACUTE PHASE PROTEIN, ΑLPHA-1-ACIDGLYCOPROTEIN, ON FEED INTAKE AND RECTAL
TEMPERATURE IN SHEEP
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ABSTRACT
In rodents, an acute phase protein, α-1-acid glycoprotein (AGP), could provide
this link by acting as a leptin receptor agonist. Serum concentrations of AGP rise
markedly during inflammation. The objective of this study was to determine the effects of
AGP on feed intake and rectal temperature in sheep. Ewes were ovariectomized,
implanted with a cannula into a lateral ventricle of the brain, and kept indoors in
individual pens. Feed intake and rectal temperature was determined for sheep in all
experiments. In the first experiment ewes (n = 4) received one of four treatments [0
(control), 0.012 (low), 0.06 (medium), or 0.30 (high) mg / kg BW AGP] into the lateral
ventricle. The study was repeated until all sheep received all treatments. In the second
experiment ewes (n = 10) received one of two treatments (0 and 3 mg / kg BW of AGP)
intravenously. In the third experiment ewes (n = 19) received peripheral treatments (IV)
of an antipyretic [0 (control) or 2.2 mg / kg BW flunixin meglumine (FLU)] 30 minutes
prior to receiving central AGP [0 (control) or 0.3 mg / kg BW of AGP]. All data were
analyzed using a mixed model analysis of variance, SAS software v9.4 (SAS Institute
Inc., Cary, NC), and tested for effects of treatment, time, and the interaction of treatment
and time. Cumulative feed intake following administration of treatments was tested for
effects of treatment. In the first experiment there was no effect of treatment (P = 0.37) on
feed intake rate and no effect of treatment (P = 0.31) on cumulative feed intake. There
was an effect of treatment (P = 0.002) on rectal temperature such that rectal temperatures
were greater (P < 0.05) following the high dose of centrally administered AGP. In the
second experiment there was no effect of treatment on feed intake rate (P = 0.98), on
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cumulative feed intake (P = 0.41) or on rectal temperature (P = 0.71). In the third
experiment there was an effect of central treatment (P < 0.0001) and an interaction of
central treatment and time (P < 0.0001) on rectal temperature such that ewes treated
centrally with AGP had greater rectal temperatures. There was no effect of peripheral
treatments (P = 0.93) on rectal temperature. These results indicate that central AGP
increases rectal temperature in sheep by pathways that do not involve prostaglandins.
Further research is needed to determine if AGP may be an important integrator of energy
balance and inflammation.

Key words: acute phase protein; orosomucoid; rectal temperature; feed intake; sheep
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INTRODUCTION
Both inflammation and sub-optimal feed intake are common in livestock during
the transition from late gestation to lactation, and both conditions are associated with
greater risk for removal from the herd and less productivity (Bradford et al., 2015). Along
with decreased feed intake, fever is also associated with inflammation (Ingvartsen and
Andersen, 2000, Sartin et al., 2008).
Leptin, an adipokine synthesized and released into circulation in proportion to the
amount of body fat, plays a crucial role in the regulation of food intake and energy
expenditure (Elmquist et al., 1998, Friedman and Halaas, 1998, Ahima and Flier, 2000,
Blache et al., 2000, Delavaud et al., 2000, Ehrhardt et al., 2000). Administration of leptin
reduces food intake, increases energy expenditure and body temperature (Halaas et al.,
1995, Barb et al., 1998, Henry et al., 1999, Morrison et al., 2001, Henry et al., 2008,
Skibicka and Grill, 2009, Henry et al., 2011). In rodents and primates leptin gene
expression in adipocytes and/or circulating concentrations of leptin are increased by
bacterial endotoxin and pro-inflammatory cytokines such as tumor necrosis factor-ɑ and
interleukin-1β (Grunfeld et al., 1996, Finck et al., 1998, Francis et al., 1999, Landman et
al., 2003). Therefore, leptin is an important hormone regulating food intake, metabolism,
and body temperature in sick animals (Harden et al., 2006).
Although leptin regulates food intake (Chilliard et al., 2005) and endocrine events
in ruminants (Morrison et al., 2001, Daniel et al., 2002, Zieba et al., 2005), plasma leptin
in ruminants is unchanged by endotoxin/inflammation (lipopolysaccharide, LPS)
(Soliman et al., 2001, Daniel et al., 2002, Soliman et al., 2002), leaving questions about
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the mechanisms by which inflammation and/or endotoxin (lipopolysaccharide; LPS)
induces changes in food intake, metabolism, and body temperature in domestic species,
like sheep and cattle. One response of animals to inflammation and models of
inflammation (endotoxin administration) is the synthesis and secretion of acute phase
proteins into circulation. These proteins are generally produced by the liver and normally
are found in low abundance in the bloodstream, but are greatly elevated during periods of
systemic inflammation (Murata et al., 2004, Petersen et al., 2004). Alpha-1-acid
glycoprotein (AGP) is an acute phase protein with diverse roles. In rodents, AGP has
anti-inflammatory and immunomodulatory properties (Hochepied et al., 2003). Bellinger
and co-workers determined that central administration of AGP induced hypophagia in
rodents (Bellinger and Mendel, 1990). The putative role of AGP was not evaluated
further until a recent publication (Sun et al., 2016) thoroughly demonstrated the role of
AGP as a hypophagic compound, signaling via the hypothalamic leptin receptor (LepR)
to reduce feed intake in rodents. While these findings are interesting, it is exciting to
consider the potential role of AGP as a link between inflammation, appetite, and
temperature regulation in ruminants, as they lack the typical inflammation-induced leptin
response observed in rodents and humans. Therefore, AGP may play an even more
important role in the effects of inflammation on appetite and temperature regulation in
ruminants than other species. The objectives of this study were to determine the effects of
central and peripheral AGP administration on feed intake and rectal temperature in sheep
and to begin to elucidate the mechanism(s) by which AGP increased rectal temperature
in sheep.
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MATERIALS AND METHODS
The Institutional Animal Care and Use Committee of the University of Tennessee
approved, in protocol number 2514-0217, all procedures and protocols used throughout
this experiment.
Animals and Maintenance
Non-lactating, non-pregnant mature (≥1 yr of age) Suffolk or Suffolk-cross
female sheep were ovariectomized to avoid cyclic variations in plasma concentrations of
steroids that may affect feed intake (Laker et al., 2011).Animals were allowed at least 2
weeks for recovery before subsequent surgeries and at least 1 month before used in any
experiments. Each sheep was then fitted with an intracerebroventricular (ICV) catheter
into a lateral ventricle of the brain as previously described (Whitlock et al., 2010). Twice
each week during the entire duration of the ICV catheter presence, antibiotics were
administered in order to prevent potential infections and help maintain catheter patency.
Catheter patency was assessed each time antibiotics were administered centrally by
attempting to withdraw approximately 1 mL of cerebrospinal fluid (CSF) from the
subcutaneous port and ICV catheter unit. The ICV antibiotic “cocktail” included
Gentamycina (40 mg / mL) and Vancomycina HCl (equivalent to 500 mg of
Vancomycin). Approximately 100 µL of the antibiotic cocktail [Gentamycin (5 mg / mL)
and Vancomycin (10 mg / mL)] was administered through the port and ICV catheter and
subsequently flushed with approximately 250 µL of sterile, nonpyrogenic, isotonic, 0.9%
sodium chloridea. Based upon previous experience, at least 80% of the ICV catheters and
subcutaneous ports were expected to remain patent for subsequent experimental use,
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therefore additional animals were prepared in anticipation of a failure rate of no more
than 20%. For all ICV injections, the skin above the port site was aseptically prepared
with 70% isopropyl alcohol prior to all central treatment and treatments were
administered through the skin and into the port via a 25-gauge Huber Point needleb
followed with 250 µl of sterile 0.9% salinea to flush the port and catheter. Ewes were kept
indoors in individual pens (approximately 3 m2) with an environment consisting of a 12hour light/dark photoperiod and approximately 22-24℃. Ewes were fed a diet (Table 1)
calculated to meet 100% of daily maintenance requirements (NRC, 1989) and had ad
libitum water.
Experiment 1- Effects of Central Administration of α-1-acid-glycoprotein on Feed
Intake and Rectal Temperature in Sheep
Ovariectomized sheep (n = 4) weighing 79.0 ± 5.0 (SD) kg, with patent ICV
catheters and ports, received 1 of 4 treatments [0 (control), 0.012 (low), 0.060 (medium),
or 0.30 (high) mg / kg BW AGP (AGP from bovine plasma)c] administered in 500 µL of
sterile, nonpyrogenic, isotonic, 0.9% sodium chloridea into the lateral ventricle. The day
before each experimental period body weights were determined. A 10-d interval was
allowed between experimental periods and each period lasted 5 days, with 3 days for
basal measure of feed intake and rectal temperature and 2 days for measurement of feed
intake and rectal temperature after experimental treatment administration. Experimental
treatments were administered as a single bolus reconstituted in 500 μL of pyrogen-free
salinea (Daniel et al., 2016). Feed intake and rectal temperature were determined at -72, 48, -24, 0, 2, 4, 6, 8, 12, 24, 36, and 48 h relative to treatment (time 0: administration of
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the respective treatments). The study was repeated until all sheep received all treatments
with a 10-d washout period between treatments.
Experiment 2- Effects of Peripheral Administration of α-1-acid-glycoprotein on Feed
Intake and Rectal Temperature in Sheep
Ewes (n = 10) weighing 78.5 ± 23.7 (SD) kg were randomly assigned to two
treatments (0 and 3.0 mg / kg BW of AGPc). Approximately 24 hours prior to treatment
administration, sheep body weights were determined and the area over each animal’s
jugular vein was desensitized by SC administration of 2% lidocaine hydrochloride
solutiond prior to inserting a cathetere into the vein. The catheter was attached to an
extension setf and then sutured to the ewe’s neck. The catheters and extension sets were
flushed with heparinized saline (0.9% sodium chloride) solution (20 U of heparin / mL).
Each ewe was infused via IV catheters with one of 2 doses (0 or 3.0 mg / kg BW) of a
commercially available AGP extracted from bovine plasmac. The dose of AGP was
selected based on the greatest dose administered centrally in experiment one (0.30 mg /
kg BW). The dose administered IV in this experiment was approximately 10-fold greater
than the greatest dose administered centrally in experiment one. Using a 10-fold greater
dose has been utilized in previous experiments when going from central to peripheral
treatment administration (Whitlock et al., 2010). AGP was administered as a single bolus
reconstituted in approximately 1 mL of pyrogen-free salinea (Daniel et al., 2016). The
sheep were offered a known amount of fresh feed ad libitum. Feed was weighed and
replaced with fresh feed and rectal temperatures were determined at -72, -48, -24, 0, 2, 4,
6, 8, 12, 24, 36 and 48 h (time 0: administration of the respective treatments).
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Following a washout period ≥10 days, sheep were included in subsequent
experimentations (Experiment 3).
Experiment 3- Effects of Peripheral Administration of a Non-Steroidal AntiInflammatory, Flunixin Meglumine, and Central Administration of α-1-acidglycoprotein on Feed Intake and Rectal Temperature in Sheep
Ewes (n = 19; weighing 85.4 ± 19.4 kg) previously ovariectomized and implanted
with an ICV catheter and port were used in this experiment. Approximately 24 hours
prior to treatment administration, body weights were determined and jugular catheterse
were inserted and maintained (as described previously in experiment 2). Sheep were
assigned to receive peripheral treatments [administered IV; 0 (SALa; equal volume of
SAL to match the other IV treatment) or 2.2 mg / kg BW flunixin meglumine (FLUg; a
cyclooxygenase inhibitory non-steroidal anti-inflammatory drug)] 30 minutes prior to
receiving centrally [administered ICV through a port and catheter into the lateral ventricle
of the brain; 500 uL of SALa or 25 mg AGPc (approximately 0.3 µg / kg BW)
administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium chloridea]. Feed
intake and rectal temperature was determined at -48, -24, -2, 0, 2, 4, 6, 8, 12, and 24 h
relative to AGP treatment (time 0: administration of the AGP treatments).
Statistical Analysis
To determine the effects on food intake rate and rectal temperature throughout the
experiments, data were analyzed using the GLIMMIX procedure for mixed model
analysis of varianceh and tested for fixed effects of treatment, time, and their interactions.
Cumulative feed intake following administration of treatments was tested for fixed effect
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of treatment using the GLIMMIX procedure for mixed model analysis of varianceh.
Values of P < 0.05 were considered significant.
RESULTS
Experiment 1
Central administration of AGP did not affect rate of feed intake (P = 0.37; Figure
1) or 48-hour cumulative feed intake (P = 0.31; Figure 2). There was an effect of time (P
< 0.0001) but no interaction of central treatment and time (P = 0.97) on feed intake rate.
Central administration of AGP increased rectal temperature (P = 0.002) and maximum
rectal temperatures in the high dose AGP group were approximately one degree greater
compared to controls at eight hours, the time at which rectal temperatures reached their
peak, and were greater (P < 0.05) following administration of the high dose compared to
all other doses administered (Figure 3). There was an effect of time (P < 0.001) on rectal
temperature and there was a tendency for an interaction of treatment and time (P = 0.07).
Experiment 2
Peripheral administration of AGP did not affect rate of feed intake (P = 0.98;
Figure 4) or 48-hour cumulative feed intake (P = 0.41; Figure 5). There was an effect of
time (P = 0.004) but no interaction of peripheral treatment and time (P =0.77) on feed
intake rate. Unlike central AGP, peripheral administration of AGP did not increase rectal
temperature (P = 0.71; Figure 6). There was no effect of time (P = 0.10) or an interaction
of treatment and time (P = 0.91) on rectal temperature.
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Experiment 3
Central administration of AGP did not affect rate of feed intake (P = 0.18; Figure
7) or 24-hour cumulative feed intake (P = 0.79; Figure 8). There was no effect of time (P
= 0.28) or an interaction of central treatment and time (P = 0.64). Moreover, peripheral
administration of AGP did not affect rate of feed intake (P = 0.88; Figure 7) or 24-hour
cumulative feed intake (P = 0.92; Figure 8). The interaction of peripheral treatment and
time (P = 0.21), peripheral by central treatment (P = 0.42), or peripheral by central
treatment by time interaction (P= 0.50) did not affect feed intake rate. The interaction of
peripheral and central treatments did not affect 24-hour cumulative feed intake (P =
0.32).
Although feed intake was not affected, central administration of AGP increased
rectal temperature (P < 0.0001). There was an effect of time (P < 0.001) and an
interaction of central AGP administration and time (P < 0.0001) on rectal temperature,
such that rectal temperatures in the AGP group were greater than controls (P < 0.05) at 2,
4, 6, 8, and 12 hours following central treatment administration (Figure 9). Peripheral
flunixin meglumine administration had no effect (P = 0.93) on rectal temperatures.
Moreover, there was no interaction of peripheral treatment and time (P = 0.35), peripheral
and central treatment (P = 0.54), or peripheral, central treatment and time (P= 0.15) on
rectal temperature.
DISCUSSION
Identifying the direct causes of intake depression is critical to preventing a
cascade of disorders in animals undergoing exaggerated systemic inflammation. Sun and
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coworkers clearly demonstrated in rodents that AGP could potentially provide a link
between inflammation and reduced feed intake via the leptin receptor (2016). Our results
show that AGP can induce an increase in rectal temperature in the ruminant model,
sheep. Our discovery of an effect of AGP on rectal temperature was found to not be
dependent on the prostaglandin pathway. While feed intake rate was not affected by AGP
administration, 24-hour cumulative feed intake was numerically greater, although not
significant, following the highest dose of centrally administered AGP.
Feed Intake
It is well-documented that during the transition period dairy cows undergo a
marked systemic inflammation accompanied by an array of responses, some of which
may be adaptive and others pathological. One of the most dramatic responses putatively
tied to exaggerated peripartum inflammation is suppressed feed intake, but the
mechanisms that underlie this relationship are poorly understood.
The acute phase protein AGP is elevated in early lactation in cattle (Cairoli et al.,
2006). A recent study in mice demonstrated that AGP has potent hypophagic effects (Sun
et al., 2016). Therefore, AGP is a candidate for inflammation-induced suppression of
food intake in ruminants. Interestingly, while AGP suppressed feed intake in ob/ob, mice
it had no effect on feed intake in db/db mice (Sun et al., 2016) leading the authors to
speculate that the effects of AGP on feed intake were mediated through the LepR. Sun et
al. (2016) confirmed their speculation when administration of AGP failed to affect feed
intake in mice with temporarily silenced LepR. Further, they ultimately demonstrated
with rat hypothalamic tissue and GT1-7 cells that AGP bound to and activated the LepR.
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In our first study, while numerically the greatest dose of AGP centrally
administered to sheep had the least cumulative food intake 48 hours later, the effect of
AGP on feed intake was not significant. Potentially the central route of AGP
administration has no effect or less effect on feed intake. However, it was observed
previously that central administration of AGP decreased feed intake in rats (Bellinger and
Mendel, 1990). While studying the effects of satietin on feed intake in rats, Bellinger and
Mendel inadvertently administered AGP. Ultimately they determined that the satietin
they were administering contained albumin and AGP, and when AGP alone was
administered centrally to rats, food intake decreased (Bellinger and Mendel, 1990).
Therefore, it is unlikely that the route by which we administered AGP to our sheep in this
first experiment was the reason feed intake was not significantly decreased.
Possibly the lack of an effect of centrally administered AGP on feed intake in
sheep was because the maximum dose given was not sufficient to elicit this response.
When compared to the dose of AGP administered centrally to rats (50 μg; or
approximately 0.20 mg / kg BW; (Bellinger and Mendel, 1990)), the maximum dose and
dose used in experiment one and three of this study, respectively, were greater
(approximately 25 mg; or approximately 0.30 mg / kg BW). Therefore, the difference in
response as it relates to feed intake between rats and sheep following central
administration of AGP cannot simply be explained by differences in doses used. That
being stated, it is still possible that a greater central dose of AGP is needed to
suppress/reduce feed intake in ruminants. If AGP truly has a role in inflammation
induced suppression of food intake in sheep, maybe the concentrations (in plasma and
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possibly in CSF) achieved during systemic inflammation in this species, and necessary to
affect feed intake, exceed that administered in our model.
Our original intentions were to administer a greater dose of AGP centrally if there
was no observed/significant effect of AGP on feed intake in the initial experiment.
However, subsequent studies of the effects of greater doses of centrally administered
AGP were not completed because of the unexpected increase in rectal temperature
following treatment administration. Once we understand better the mechanism(s) by
which AGP increases rectal temperature in sheep we will likely administer greater doses
centrally.
The effects of AGP on feed intake in mice by Sun et al., (2016) were observed
following peripheral administration (intraperitoneal and IV). Thus, we administered AGP
peripherally in our second experiment. The dose of AGP used in the second experiment
(~3.0 mg / kg IV; ~ 250 mg) was 10-fold greater than the greatest dose used in our first
experiment (~0.30 mg / kg ICV; ~25 mg) to determine if the lack of an effect was
possibly a result of the route by which the treatments were administered. However,
similar to the first experiment, AGP had no effect on feed intake in sheep (cumulative or
feed intake rate). Sun et al. (2016) administered 100 mg / kg IV or ~ 2 mg total to reduce
feed intake in mice. Based upon their reported body weights, assumed blood volumes,
and previously reported circulating concentrations of AGP in mice (Kopf et al., 1994), it
is likely that the 2 mg total dose of AGP administered to the mice increased their plasma
AGP by approximately 670%. In cattle, serum concentrations of AGP vary. Serum
concentrations of AGP range from approximately 200 to 450 mg / L in healthy cattle and
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increase to ≥ 1000 mg / L during acute inflammation (Ceciliani et al., 2012). Recently we
observed a negative association between feed intake and serum AGP concentrations in
periparturient dairy cattle (unpublished). In that study a reduction in periparturient intake
of feed in dairy cattle was associated with an increase of approximately 40% in plasma
AGP. While this association does not necessarily confirm causation, it is interesting to
consider in light of what was previously observed and reported regarding AGP and feed
intake by Sun and others (2016).
While there are very few recorded reference ranges for serum concentrations of
AGP in sheep, a 30 day experiment was conducted with the concentrations of the control
sheep being approximately 100 mg / L (Eckersall et al., 2007). Concentrations in other
species (mice, rats, and swine) are similar to those observed/reported in cattle (Pous et al.,
1990, Caperna et al., 2017). Therefore, it is likely that serum concentrations of AGP in
healthy sheep are not that divergent from other species. Comparatively, if our assumption
is true, that the normal circulating concentration of AGP in sheep is approximately 300
mg / L, the IV dose administered to the sheep in this study likely increased their
(concentration and total) serum AGP by 10 to 13%. If AGP does suppress feed intake in
ruminants during inflammation, it is possible that the IV dose of AGP administered to our
sheep was not comparable to increases in serum or plasma normally achieved during
systemic inflammation associated with suppressed feed intake. Therefore, it is possible
that a greater IV dose could have an effect on feed intake in sheep. Subsequent analyses
and validation of AGP assays for serum and plasma of sheep associated with our
experiments are underway and will likely provide greater insight into the circulating
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concentrations of AGP in healthy and diseased (inflammation models) animals in this
species.
Additionally, bovine AGP includes at least five glycosylations and potentially
eight phosphorylation sites (Ceciliani et al., 2012). Being similar in humans and rats who
have six glycosylations (Fournier et al., 2000). Moreover, it is clear that systemic
inflammation alters AGP glycosylation (Kreisman and Cobb, 2012). Therefore, it is
possible that there are unique AGP glycosylations associated with inflammation that
make the AGP molecule respond differently at the site of the LepR. Because of the
complexity of this protein and changes associated with inflammation, we cannot rule out
that the observations made during our studies resulted from variation/diversity in
glycosylation of the AGP administered to our animals. However, we did use the same lot
of AGP for all studies reported herein.
Rectal Temperature
An unexpected and previously unreported effect of central administration of AGP
was increased rectal temperature in sheep. While this was a surprising and interesting
observation, the mechanism(s) by which AGP increased rectal temperature in sheep was
not immediately clear/obvious. Fever, an elevation in body temperature, may be the result
of many infectious or inflammatory diseases. To elicit a fever, the infection/inflammatory
cause triggers cytokine production which then use specific routes crossing the bloodbrain-barrier to initiate a febrile response. A rise in body temperature is necessary in
many cases for the body to recover from or fight back against the initial foreign cause
(for more in-depth review see (Evans et al., 2015)).
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During the first experiment, we observed that central administration of AGP
increased rectal temperature in sheep. Previous research regarding the effects of AGP on
feed intake did not determine body temperature; therefore, this is a novel and unexpected
finding. One potential concern regarding the increased rectal temperature in response to
central AGP administration was that the administered bovine AGP might have been
contaminated with endotoxin. To help ensure that the increase temperature in response to
central AGP was not because of contamination with endotoxin, we determined that our
AGP did not contain endotoxin using a limulus amebocyte lysate test. Moreover, the
timing of the increased rectal temperature following central administration of AGP was
not consistent with previous endotoxin models, in that the increase in temperature was
later than what would have been observed following endotoxin administration (Kabaroff
et al., 2006, Feng et al., 2010, Ranjan et al., 2011). Once we confirmed that the AGP did
not contain endotoxin we turned our attention to other possible mechanisms.
It has been determined that central leptin administration in rats not only reduced
feed intake but also increased body temperature (Luheshi et al., 1999, Turek et al., 2004,
Skibicka and Grill, 2009). If the effect of AGP to suppress food intake in rodents is
mediated through the LepR as supported by Sun and others (2016), then it is reasonable
to speculate that AGP, like leptin, could increase body temperature. It could be that the
effects of AGP or leptin on body temperature in rodents and/or sheep are more sensitive
than the effects of either of them on feed intake. However, Luheshi et al. (1999)
administered various quantities of leptin centrally to rats and found that even their lowest
dose of 0.4 ug / rat caused a significant decrease in food intake, but did not induce a
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temperature. Even given this information, we cannot rule out the possible differences
between species. We concluded that we should administer AGP by a different route based
on the previous work in mice.
Unlike central, peripheral administration of AGP had no effect on rectal
temperatures. The peripheral dose of AGP needed to increase rectal temperature may not
have been achieved. When administering leptin peripherally in rodents, concentrations
that caused an increase in temperature were 1 mg / rat (~3.5 mg / kg) albeit at a lower
increase then the central route (Luheshi et al., 1999). Potentially more than a 10-fold
greater dose, such as a 100-fold greater dose than the central dose would get the same
results as the central doses. Given that central administration of AGP increased rectal
temperature in sheep in experiment one, we speculate that the dose given IV in this study
may not have been sufficient to elicit a response to affect feed intake or rectal
temperature.
While studying the effects of leptin on feed intake and body temperature in rats,
Luheshi et al. (1999) administered a cyclo-oxygenase inhibitor, flurbiprofen, and found it
had no effect on feed intake but was able to block the leptin induced increased
temperature. Therefore, to help elucidate the mechanism(s) by which central
administration of AGP increases rectal temperature in sheep we designed an experiment
to eliminate pyrogenic/fever causing pathways that involve prostaglandins. We
administered flunixin meglumine, a non-steroidal anti-inflammatory drug and potent
cyclo-oxygenase inhibitor that has antipyrogenic effects involving inhibition of
endogenous pyrogens (IL-1 and TNF) and prostaglandin PGE2 (McKellar et al., 1989,
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Lees and Taylor, 1991). Pretreatment with flunixin meglumine had no effect on increased
rectal temperature following central administration of AGP. To keep our experimental
models the same we continued to monitor feed intake and found there was no effect on
feed intake. Because we observed a tendency to reduce cumulative feed intake 48 hour
post treatment, we regret not determining/measuring feed intake and rectal temperatures
out to 48 hours in this subsequent study. We concluded that central AGP administration
increases rectal temperature in sheep by a mechanism(s) independent of prostaglandin
synthesis.
Therefore, it is plausible that central administration of AGP is having an effect on
body temperature/rectal temperature through actions at the LepR. Moreover, if this effect
is mediated through the LepR, then it is likely that increased rectal temperature following
central AGP is affecting the melanocortin system through actions at the LepR to
ultimately increase body temperature (Turek et al., 2004, Skibicka and Grill, 2009).
Subsequent studies designed to determine the mechanism(s) by which AGP increases
rectal temperature in sheep might focus on the effects of blocking hypothalamic
melanocortin receptors prior to central administration of AGP.
CONCLUSIONS
In summary, although there are many open questions regarding alpha-1-acid
glycoproteins’ effects on feed intake, we did discover a novel effect on rectal
temperature. While AGP did not decrease feed intake in our sheep model, central
administration of AGP did increase rectal temperature in sheep. It has been stated that
leptin induced increase in body temperature in rats will plateau even when given up to 10
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times greater than the normal plasma concentrations of leptin (Luheshi et al., 1999).
Therefore, it is plausible to assume, if the temperature response was maximal in this
study, that higher amounts of AGP may decrease feed intake in sheep while not causing
any greater increase in rectal temperature. Furthermore, administration of flunixin
meglumine did not abolish the increase rectal temperature brought on by central
administration of AGP, removing the possibility of prostaglandin pathways involved in
AGP-stimulated rectal temperature and it would be reasonable to move forward by
researching AGP actions on the melanocortin pathway in this area. Alpha-1-acid
glycoprotein may be an important integrator of inflammation, food intake and body
temperature in ruminants, however, further research is needed to completely elucidate
and confirm its role in these areas.
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CHAPTER III
CONCLUSIONS
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Inflammation and reduced feed intake are common in dairy cows in the transition
to lactation, and both conditions are associated with risk for removal from the herd and
less productivity. Poor feed intake is associated with other negative outcomes detrimental
to lactation efficiency and the well-being of dairy cows (Grummer, 1995, Huzzey et al.,
2007, Goldhawk et al., 2009). Alpha-1-acid glycoprotein (AGP) has been shown to signal
via the leptin receptor in rodents to reduce feed intake (Sun et al., 2016). It has been
discovered that AGP (Cairoli et al., 2006), but not leptin, increases as a result of an
inflammatory response in ruminants, therefore we hypothesized that AGP may be the
factor reducing feed intake during the transition period in ruminants. The objectives were
to test the effects of AGP (1) centrally and (2) peripherally on feed intake and rectal
temperature then (3) determine the mechanism(s) in which central administration of AGP
increases rectal temperature.
In the first experiment, it was hypothesized that central AGP would affect feed
intake in the ruminant model, sheep. Feed intake was not reduced. This could be because
of the route of administration although in rodents both central and peripheral routes of
AGP reduced feed intake so this is unlikely. The greatest dose of AGP had the least
cumulative food intake 48 hours post treatment, but the effect was not significant.
Potentially a higher dose would elicit a response, however a increase in rectal
temperature was discovered at this dose. Another possible explanation is the many
glycosylations of AGP may cause the protein to react differently. The increase in rectal
temperature is a novel finding. Other research monitoring AGP effect on feed intake did
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not record body temperature. High amounts of leptin can cause an increase in body
temperature, therefore, although not expected, it can be understood.
In the second experiment, we hypothesized peripheral AGP would affect feed
intake and body temperature in sheep. Using 10 times the highest dose given in
experiment one, there was no effect on feed intake or rectal temperature. It may be that
the AGP concentrations, in plasma, during an inflammatory response are much higher
then what was given. Potentially a greater dose is needed peripherally since the dose
administered by this route did not induce a fever.
In the third experiment, flunixin meglumine, a cyclo-oxygenase inhibitor was
administered peripherally 30 minutes prior to central AGP. The administration of
peripheral flunixin meglumine had no effect on the temperature rise via central AGP.
There was once again a rise in temperature such that ewes treated centrally with AGP had
greater rectal temperatures at 2, 4, 6, 8, and 12 hours relative to ewes treated centrally
with saline. These results suggest AGP using a mechanism(s) independent of the
prostaglandin pathway to increase temperature.
Alpha-1-acid glycoprotein could be a potential marker for inflammatory or
infectious disease in ruminants. Although AGP did not reduce feed intake in these
models, the induction of a rectal temperature was discovered. The temperature is not
induced through the prostaglandin pathway and future research could focus on the
melanocortin pathway. If the fever can be abolished further research can be achieved with
higher doses.
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Figure 1. Effects of central α-1-acid-glycoprotein (AGP) administration on feed intake
rate (kg / hour) in sheep (+/- SEM). Ewes were treated with 1 of 4 treatments [0 (control;
n = 4), 0.012 (low; n = 4), 0.060 (medium; n = 4), or 0.30 (high; n = 4) mg / kg BW
AGP] administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium chloride
into the lateral ventricle at time 0 hrs to yield four possible treatment groups. The study
was repeated until all sheep received all treatments with a 10-day washout period
between treatments. There was an effect of time (P < 0.0001) and no effect of treatment
(P = 0.37), or treatment x time interaction (P = 0.97) on feed intake rate. CON, control;
LOW, low; MED, medium; HIGH, high.
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Figure 2. Effects of central α-1-acid-glycoprotein (AGP) administration on cumulative
feed intake (kg) in sheep (+/- SEM). Ewes were treated with 1 of 4 treatments [0 (control;
n = 4), 0.012 (low; n = 4), 0.060 (medium; n = 4), or 0.30 (high; n = 4) mg / kg BW
AGP] administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium chloride
into the lateral ventricle at time 0 hrs to yield four possible treatment groups. The study
was repeated until all sheep received all treatments with a 10-day washout period
between treatments. There was no effect of treatment (P = 0.31) on 48 hour cumulative
feed intake. CON, control; LOW, low; MED, medium; HIGH, high.
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Figure 3. Effects of central α-1-acid-glycoprotein (AGP) administration on rectal
temperatures (°C) in sheep (+/- SEM). Ewes were treated with 1 of 4 treatments [0
(control; n = 4), 0.012 (low; n = 4), 0.060 (medium; n = 4), or 0.30 (high; n = 4) mg / kg
BW AGP] administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium
chloride into the lateral ventricle at time 0 hrs to yield four possible treatment groups.
The study was repeated until all sheep received all treatments with a 10-day washout
period between treatments. There was a tendency for an interaction of treatment and time
(P = 0.07), and there was an effect of time (P < 0.0001) and treatment (P = 0.002) on
rectal temperature. Rectal temperatures were greater (P < 0.05) with high dose compared
to other doses given. CON, control; LOW, low; MED, medium; HIGH, high.
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Figure 4. Effects of peripheral α-1-acid-glycoprotein (AGP) administration on feed intake
rate (kg / hour) in sheep (+/- SEM). Ewes were treated with one of two treatments [0
(control; n = 5) and 3.0 (AGP; n = 5) mg / kg BW of AGP] infused via IV catheters at
time 0 hrs to yield two possible treatment groups. The dose of AGP was selected based
on the greatest dose administered centrally in experiment one (0.30 mg / kg BW). There
was no effect of IV treatment (P = 0.98) or treatment x time interaction (P = 0.77), but
there was an effect of time (P = 0.004) on feed intake rate. CON, control.
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Figure 5. Effects of peripheral α-1-acid-glycoprotein (AGP) administration on cumulative
feed intake (kg) in sheep (+/- SEM). Ewes were treated with one of two treatments [0
(control; n = 5) and 3.0 (AGP; n = 5) mg / kg BW of AGP] infused via IV catheters at
time 0 hrs to yield two possible treatment groups. The dose of AGP was selected based
on the greatest dose administered centrally in experiment one (0.30 mg / kg BW). There
was no effect of IV treatment (P = 0.41) on 48 hour cumulative feed intake. CON,
control.
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Figure 6. Effects of peripheral α-1-acid-glycoprotein (AGP) administration on rectal
temperatures (°C) in sheep (+/- SEM). Ewes were treated with one of two treatments [0
(control; n = 5) and 3.0 (AGP; n = 5) mg / kg BW of AGP] infused via IV catheters at
time 0 hrs to yield two possible treatment groups. The dose of AGP was selected based
on the greatest dose administered centrally in experiment one (0.30 mg / kg BW). There
was no effect of treatment (P = 0.71), time (P = 0.10), or treatment x time interaction (P =
0.91) on rectal temperature. CON, control.
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Figure 7. Effects of central α-1-acid-glycoprotein (AGP) and peripheral flunixin
meglumine (FLU) administration on feed intake rate (kg / hour) in sheep (+/- SEM).
Ewes were treated with peripheral treatments [administered IV; 0 (control) or 2.2 mg / kg
BWFLU] 30 minutes prior to receiving centrally [administered ICV through a port and
catheter into the lateral ventricle of the brain; 0 (control) or 25 mg AGP (approximately
0.30 mg / kg BW) to yield four possible treatment combinations (CON / CON, n=4; FLU
/ CON, n=5; CON / AGP, n =5; FLU / AGP, n=5). There was no effect of central
treatment administration (P = 0.18), time (P = 0.28) or central treatment by time
interaction (P = 0.64) on feed intake rate. Moreover, there was no effect of intravenous
treatment (P = 0.88), intravenous treatment by time interaction (P = 0.21), intravenous by
central treatment (P = 0.42), or intravenous by central treatment by time interaction (P=
0.50) on feed intake rate. CON, control.
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Figure 8. Effects of central α-1-acid-glycoprotein (AGP) and peripheral flunixin
meglumine (FLU) administration on cumulative feed intake (kg) in sheep (+/- SEM).
Ewes were treated with peripheral treatments [administered IV; 0 (control) or 2.2 mg / kg
BWFLU] 30 minutes prior to receiving centrally [administered ICV through a port and
catheter into the lateral ventricle of the brain; 0 (control) or 25 mg AGP (approximately
0.30 mg / kg BW) to yield four possible treatment combinations (CON / CON, n=4; FLU
/ CON, n=5; CON / AGP, n =5; FLU / AGP, n=5). There was no effect of central
treatment (P = 0.79), intravenous treatment (P = 0.92) or their interaction (P = 0.32) on
24 hour cumulative feed intake. CON, control.
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Figure 9. Effects of central α-1-acid-glycoprotein (AGP) and peripheral flunixin
meglumine (FLU) administration on rectal temperatures (°C) in sheep (+/- SEM). Ewes
were treated with peripheral treatments [administered IV; 0 (control) or 2.2 mg / kg
BWFLU] 30 minutes prior to receiving centrally [administered ICV through a port and
catheter into the lateral ventricle of the brain; 0 (control) or 25 mg AGP (approximately
0.30 mg / kg BW) to yield four possible treatment combinations (CON / CON, n=4; FLU
/ CON, n=5; CON / AGP, n =5; FLU / AGP, n=5). There was an effect of central
treatment administration (P < 0.0001), time (P < 0.0001) and central treatment by time
interaction (P < 0.0001) on rectal temperature such that ewes treated centrally with AGP
had greater rectal temperatures at 2, 4, 6, 8, and 12 h relative to ewes treated centrally
with control. There was no effect of intravenous treatment (P = 0.93), intravenous
treatment by time interaction (P = 0.35), intravenous by central treatment (P = 0.54), or
intravenous by central treatment by time interaction (P= 0.15) on rectal temperature. (*)
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indicates time points at which AGP treated ewes differed from CON treated ewes (P <
0.05). CON, control.
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Table 1. Feed ration composition (DM) of sheep
Ingredient

Cotton seed hulls
Molasses

%

25.00
7.00

Cracked corn

56.00

Soybean meal

10.00

Calcium phosphate

0.20

Limestone calcium

1.00

Ade premix

0.10

TM salt

0.50

Dynamate

0.20

Nutrient composition
Dry matter, %
89.7
CP, %
11.7
ADF, %
24.30
aNDF, %
35.8
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Table # 1. Continued
Ingredient

%

TDN, %

75.00

Calcium, %

0.74

Phosphorus, %

0.37

Potassium, %

1.08

Magnesium, %

0.23

Sodium, %

0.26

Sulfur, %

0.25

Aluminum, mg/kg

132.00

Cobalt, mg/kg

<0.20

Copper, mg/kg

5.06

Iron, mg/kg
Magnesium, mg/kg
Molybdenum, mg/kg
Zinc, mg/kg

157.00
18.70
1.22

30.70

*DM reported on an as fed basis
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